New drug duo tested for Tough-to-Treat blood cancer
Disease control
Terminated
This early-stage study tested the safety and best dose of a two-drug combination (parsaclisib and chidamide) for adults with peripheral T-cell lymphoma that has come back or not responded to prior treatments. The main goals were to see how well patients tolerated the drugs and to…
Phase: PHASE1 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC